1. Home
  2. NMG vs LCTX Comparison

NMG vs LCTX Comparison

Compare NMG & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nouveau Monde Graphite Inc.

NMG

Nouveau Monde Graphite Inc.

N/A

Current Price

$0.94

Market Cap

292.7M

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$1.01

Market Cap

251.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NMG
LCTX
Founded
2011
1990
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
292.7M
251.4M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
NMG
LCTX
Price
$0.94
$1.01
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$3.68
★ $5.50
AVG Volume (30 Days)
438.5K
★ 1.4M
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $14,556,000.00
Revenue This Year
N/A
$4.38
Revenue Next Year
N/A
$10.80
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 53.24
52 Week Low
$0.87
$0.88
52 Week High
$3.59
$2.09

Technical Indicators

Market Signals
Indicator
NMG
LCTX
Relative Strength Index (RSI) 35.55 51.56
Support Level $0.87 $0.89
Resistance Level $2.42 $1.05
Average True Range (ATR) 0.06 0.06
MACD 0.02 0.01
Stochastic Oscillator 40.00 67.61

Price Performance

Historical Comparison
NMG
LCTX

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: